The low-volume appeals settlement option will be limited to those with fewer than 500 Medicare Part A or Part B claim appeals pending with the Office of Medicare Hearings and Appeals and the Medicare Appeals Council as of Nov. 3, with a total billed amount of $9,000 or less per appeal. CMS said it will settle eligible appeals at 62 percent of the net allowed amount.
The Office of Medicare Hearings and Appeals will also be expanding the settlement conference facilitation process for certain appellants that are not eligible for the low-volume appeals option. CMS said more information about this initiative will be available on the OMHA website in coming weeks.
CMS is launching the new settlement options to clear the significant backlog of Medicare appeals that has resulted in a nearly three-year adjudication process for each Medicare claim that is denied.
More articles on healthcare finance:
Tenet’s net loss balloons to $367M as investor agitation builds
15-bed Missouri hospital’s 2,353% revenue increase raises red flags with regulators
CHS to sell additional hospitals worth $2B in revenue
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
